PSMA-PET in Addition to mpMRI and Biopsies to Select Prostate Cancer Patients for Focal Therapy.

Bart Geboers Dennie MeijerWilliam CounterAlexandar Blazevski James E Thompson Paul DoanWilliam GondoputroAthos KatelarisAnne-Maree HaynesWarick DelpradoGordon O'NeillCarlo YuenAndre N VisPim J Van LeeuwenBao HoVictor LiuJonathan LeeMaarten L DonswijkDaniela Oprea-LagerMatthijs J V ScheltemaLouise EmmettPhillip D Stricker

Published in: BJU international (2023)

Addition of PSMA-PET to the conventional workup by mpMRI and systematic biopsies could improve selection for hemi-ablative FT and guide exclusion of patients for whom whole gland treatments might be a more suitable treatment option.

Keyphrases

pet ct
pet imaging
end stage renal disease
computed tomography
positron emission tomography
prostate cancer
ejection fraction
newly diagnosed
peritoneal dialysis
ultrasound guided
stem cells
cell therapy
combination therapy
benign prostatic hyperplasia